About Abceutics
Abceutics Inc. was founded in 2020 and is based in Buffalo, United States. Operations are centered on biotechnology as a preclinical-stage biopharmaceutical company. Antibody-drug conjugates are enhanced for cancer treatment, with development directed toward new autoimmune drugs. Patient outcomes are targeted for improvement through these efforts in the sector.
- Headquarter Buffalo, United States
- Founders Larry C Wienkers
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Abceutics
Detailed funding history for Abceutics
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Abceutics
Abceutics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Merck.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Pharmaceutical products are manufactured and marketed worldwide.
|
Locked | Locked | Locked |
Investor details for Abceutics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Abceutics
Investment portfolio details for Abceutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Abceutics
Detailed financials for Abceutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Abceutics Comparisons
Peer comparison for Abceutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Abceutics
Detailed competitors of Abceutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Abceutics
Complete news archive for Abceutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Abceutics
Abceutics was founded in 2020.
Abceutics is headquartered in Buffalo, United States. It is registered at Buffalo, New York, United States.
Abceutics Inc. was founded in 2020 and is based in Buffalo, United States. Operations are centered on biotechnology as a preclinical-stage biopharmaceutical company. Antibody-drug conjugates are enhanced for cancer treatment, with development directed toward new autoimmune drugs. Patient outcomes are targeted for improvement through these efforts in the sector.
Abceutics has 1 investor. Key investors include Merck.